SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-059933
Filing Date
2018-10-02
Accepted
2018-10-02 14:31:54
Documents
1
Period of Report
2018-10-01

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 8983
  Complete submission text file 0001104659-18-059933.txt   11365
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Reporting) CIK: 0000310158 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 181100785
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889
Business Address ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889 908-740-4000
Merck Sharp & Dohme Corp. (Reporting) CIK: 0000942443 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 181100786

Mailing Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA INC (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences